爱默生物科技有限公司
厦门市翔安区民安街道莲亭路811号401
(+86) 0592-7080189
support@amogene.com
Product Description
Y27632 is a cell-permeable small molecule Rho-associated kinase (ROCK) inhibitor [1]. Y27632 has been found to prevent apoptosis as well as enhance the survival and cloning efficiency of dissociated human embryonic stem (ES) cells without affecting their self-renewal properties or pluripotency [2]. This molecule has also been shown to enhance survival during the transplantation of ES cell-derived neural precursors [3]. Y27632 in combination with Pifithrin-µ significantly improves cell recovery after cryopreservation [4].
Catalog No.: | MD-0025 |
Quantity: | 2mg (10mM in 624.4μl DMSO) |
Alternate Name: | (1R,4r)-4-((R)-1-aminoethyl)-N-(pyridine-4-yl)cyclohexanecarboxamide dihydrochloride |
CAS Number: | 146986-50-7 |
Chemical Formula: | C14H23Cl2N3O |
Molecular Weight: | 320.3 g/mol |
Purity: | >Greater than 98% by HPLC analysis |
Structure: | |
Applications: | MAINTENANCE AND SELF-RENEWAL
REPROGRAMMING
DIFFERENTIATION
|
Product Use: | Y27632 is for research use only. It is not approved for human or animal use, or for application in in vitro diagnostic procedures. |
Storage & stability: | Store aliquots at -20°C. Stock solutions are stable for 6 months when stored as directed. |
References
[1] Ishizaki, T., Uehata, M., Tamechika, I., Keel, J., Nonomura, K., Maekawa, M., and Narumiya, S. (2000) Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 57: 976-983.
[2] Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya, T., Takahashi, J.B., Nishikawa, S., Nishikawa, S., Muguruma, K., and Sasai, Y. (2007) A ROCK inhibitor permits survival of dissociated human embryonic stem cells.Nat Biotechnol 25: 681-686.
[3] Koyanagi, M., Takahashi, J., Arakawa, Y., Doi, D., Fukuda, H., Hayashi, H., Narumiya, S., and Hashimoto, N. (2008) Inhibition of the Rho/ROCK pathway reduces apoptosis during transplantation of embryonic stem cell-derived neural precursors.J. Neurosci Res. 86: 270-280.
[4] Xu, X., Cowley, S., Flaim, C.J., James, W., Seymour, L.W., Cui, Z. (2010) Enhancement of cell recovery for dissociated human embryonic stem cells after cryopreservation. Biotechnol Prog. 26: 781-788.
[1] Ishizaki, T., Uehata, M., Tamechika, I., Keel, J., Nonomura, K., Maekawa, M., and Narumiya, S. (2000) Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 57: 976-983.
[2] Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya, T., Takahashi, J.B., Nishikawa, S., Nishikawa, S., Muguruma, K., and Sasai, Y. (2007) A ROCK inhibitor permits survival of dissociated human embryonic stem cells.Nat Biotechnol 25: 681-686.
[3] Koyanagi, M., Takahashi, J., Arakawa, Y., Doi, D., Fukuda, H., Hayashi, H., Narumiya, S., and Hashimoto, N. (2008) Inhibition of the Rho/ROCK pathway reduces apoptosis during transplantation of embryonic stem cell-derived neural precursors.J. Neurosci Res. 86: 270-280.
[4] Xu, X., Cowley, S., Flaim, C.J., James, W., Seymour, L.W., Cui, Z. (2010) Enhancement of cell recovery for dissociated human embryonic stem cells after cryopreservation. Biotechnol Prog. 26: 781-788.